RCUS
Price
$8.56
Change
-$0.05 (-0.58%)
Updated
May 22, 11:28 AM (EDT)
Capitalization
911.67M
70 days until earnings call
SPRY
Price
$14.31
Change
+$0.09 (+0.63%)
Updated
May 22, 11:33 AM (EDT)
Capitalization
1.4B
76 days until earnings call
Interact to see
Advertisement

RCUS vs SPRY

Header iconRCUS vs SPRY Comparison
Open Charts RCUS vs SPRYBanner chart's image
Arcus Biosciences
Price$8.56
Change-$0.05 (-0.58%)
Volume$200
Capitalization911.67M
ARS Pharmaceuticals
Price$14.31
Change+$0.09 (+0.63%)
Volume$3.52K
Capitalization1.4B
RCUS vs SPRY Comparison Chart
Loading...
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RCUS vs. SPRY commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCUS is a StrongBuy and SPRY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (RCUS: $8.61 vs. SPRY: $14.22)
Brand notoriety: RCUS and SPRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RCUS: 98% vs. SPRY: 78%
Market capitalization -- RCUS: $911.67M vs. SPRY: $1.4B
RCUS [@Biotechnology] is valued at $911.67M. SPRY’s [@Biotechnology] market capitalization is $1.4B. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RCUS’s FA Score shows that 0 FA rating(s) are green whileSPRY’s FA Score has 0 green FA rating(s).

  • RCUS’s FA Score: 0 green, 5 red.
  • SPRY’s FA Score: 0 green, 5 red.
According to our system of comparison, SPRY is a better buy in the long-term than RCUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RCUS’s TA Score shows that 5 TA indicator(s) are bullish while SPRY’s TA Score has 7 bullish TA indicator(s).

  • RCUS’s TA Score: 5 bullish, 3 bearish.
  • SPRY’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, SPRY is a better buy in the short-term than RCUS.

Price Growth

RCUS (@Biotechnology) experienced а +0.82% price change this week, while SPRY (@Biotechnology) price change was +17.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.52%. For the same industry, the average monthly price growth was +6.38%, and the average quarterly price growth was -2.04%.

Reported Earning Dates

RCUS is expected to report earnings on Jul 31, 2025.

SPRY is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+3.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRY($1.4B) has a higher market cap than RCUS($912M). SPRY YTD gains are higher at: 34.787 vs. RCUS (-42.176). SPRY has higher annual earnings (EBITDA): -3.08M vs. RCUS (-269M). RCUS has more cash in the bank: 978M vs. SPRY (314M). SPRY has less debt than RCUS: SPRY (42K) vs RCUS (60M). RCUS has higher revenues than SPRY: RCUS (258M) vs SPRY (89.1M).
RCUSSPRYRCUS / SPRY
Capitalization912M1.4B65%
EBITDA-269M-3.08M8,725%
Gain YTD-42.17634.787-121%
P/E RatioN/A152.50-
Revenue258M89.1M290%
Total Cash978M314M311%
Total Debt60M42K142,857%
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RCUSSPRY
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
70%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 9 days ago
83%
Bearish Trend 11 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X109678.0800002886.992200
+2.70%
Bitcoin cryptocurrency
GME28.05-0.46
-1.61%
GameStop Corp
SPY582.86-9.99
-1.69%
SPDR® S&P 500® ETF
AAPL202.09-4.77
-2.31%
Apple
TSLA334.62-9.20
-2.68%
Tesla

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with APGE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then APGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
-2.93%
APGE - RCUS
48%
Loosely correlated
-0.40%
ACLX - RCUS
48%
Loosely correlated
+8.26%
XNCR - RCUS
47%
Loosely correlated
-7.62%
IMNM - RCUS
46%
Loosely correlated
-7.48%
IDYA - RCUS
46%
Loosely correlated
-2.45%
More

SPRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with ANAB. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then ANAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRY
1D Price
Change %
SPRY100%
-0.77%
ANAB - SPRY
35%
Loosely correlated
-1.40%
RCUS - SPRY
34%
Loosely correlated
-2.93%
APGE - SPRY
34%
Loosely correlated
-0.40%
AURA - SPRY
34%
Loosely correlated
+0.51%
SYRE - SPRY
34%
Loosely correlated
-4.03%
More